Whereas we had initially dismissed this variant because it did not show convincing co-segregation with disease, the fact that Park et al. had also found a protein-truncation variant in XRCC2, prompted a mutation scan of a large population of familial breast cancer cases and controls. This evidence concerns the gene XRCC2 and breast carcinoma.